![Sara Sande](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sara Sande
Direttore/Membro del Consiglio presso
EXPRES2ION BIOTECH HOLDING AB
Profilo
Sara Sande is currently Director at Biosyntia ApS, Independent Director at Expres2ion Biotech Holding AB since 2021, Director at ExpreS2ion Biotechnologies ApS, Director at Agreena ApS, Director at Monta ApS, Vice President at Origio A, and Partner at Danmarks Eksport- og Investeringsfond.
Former positions include Independent Director at Hydract A, Head-Grain & Beverages Sales at Novozymes A, and Vice President-Global Commercial Development at CooperSurgical, Inc. Education includes a graduate degree from the University of Copenhagen conferred in 2002.
Posizioni attive di Sara Sande
| Società | Posizione | Inizio |
|---|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Direttore/Membro del Consiglio | 26/05/2021 |
Origio A/S
 Origio A/S BiotechnologyHealth Technology Manufactures and markets assisted reproduction technologies and related human reproductive products | Corporate Officer/Principal | - |
Biosyntia ApS
 Biosyntia ApS BiotechnologyHealth Technology Provides services in synthetic biology and metabolic engineering fields | Direttore/Membro del Consiglio | - |
Agreena ApS
 Agreena ApS Packaged SoftwareTechnology Services Operates as an agricultural technology company that offers soil carbon platform | Direttore/Membro del Consiglio | - |
Monta ApS
 Monta ApS Packaged SoftwareTechnology Services Provides EV ecosystem software solutions | Direttore/Membro del Consiglio | - |
ExpreS2ion Biotechnologies ApS
 ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology Operates as a biotech company which engages in the field of protein production in Drosophila Schneider-2 cells | Direttore/Membro del Consiglio | - |
Danmarks Eksport- og Investeringsfond
 Danmarks Eksport- og Investeringsfond Investment ManagersFinance EIFO invests in small and medium-sized companies located in Denmark. The firm targets companies operating across a broad range of sectors and industries. It provides financing in the form of equity and debt with an investment size of DKK 5 - 200 million. It also takes a seat on the board of directors. | Investitore di Private Equity | - |
Precedenti posizioni note di Sara Sande
| Società | Posizione | Fine |
|---|---|---|
CooperSurgical, Inc.
 CooperSurgical, Inc. Medical SpecialtiesHealth Technology Produces and markets medical devices for fertility & women's health care | Corporate Officer/Principal | - |
Novozymes A/S
 Novozymes A/S Chemicals: SpecialtyProcess Industries Manufactures and sells specialty chemicals | Corporate Officer/Principal | - |
| ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
Formazione di Sara Sande
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
43
Relazioni di 1° grado
11
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
Novozymes A/S
Novozymes A/S Chemicals: SpecialtyProcess Industries Manufactures and sells specialty chemicals | Process Industries |
CooperSurgical, Inc.
CooperSurgical, Inc. Medical SpecialtiesHealth Technology Produces and markets medical devices for fertility & women's health care | Health Technology |
Danmarks Eksport- og Investeringsfond
Danmarks Eksport- og Investeringsfond Investment ManagersFinance EIFO invests in small and medium-sized companies located in Denmark. The firm targets companies operating across a broad range of sectors and industries. It provides financing in the form of equity and debt with an investment size of DKK 5 - 200 million. It also takes a seat on the board of directors. | Finance |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Origio A/S
Origio A/S BiotechnologyHealth Technology Manufactures and markets assisted reproduction technologies and related human reproductive products | Health Technology |
ExpreS2ion Biotechnologies ApS
ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology Operates as a biotech company which engages in the field of protein production in Drosophila Schneider-2 cells | Health Technology |
Biosyntia ApS
Biosyntia ApS BiotechnologyHealth Technology Provides services in synthetic biology and metabolic engineering fields | Health Technology |
Expres2ion Biotech Holding AB
 Expres2ion Biotech Holding AB BiotechnologyHealth Technology Engages in the development of a portfolio of vaccines for diseases such as COVID-19, influenza, and breast cancer | Health Technology |
Hydract A/S
 Hydract A/S Industrial MachineryProducer Manufacturing Develops and manufactures water-hydraulic process valves and actuators for the food, beverage, dairy and pharmaceutical industries | Producer Manufacturing |
Agreena ApS
Agreena ApS Packaged SoftwareTechnology Services Operates as an agricultural technology company that offers soil carbon platform | Technology Services |
Monta ApS
Monta ApS Packaged SoftwareTechnology Services Provides EV ecosystem software solutions | Technology Services |
